SEC Form 4 · accession 0001209191-18-028611
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Director
Period of report
May 7, 2018
Accepted (ET)
May 8, 2018 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.67 | May 7, 2018 | A | 53,000 | A | — | May 6, 2028 | Common Stock | 53,000 | 53,000 | D |
Explanation of responses
- F1The shares vest as follows: 1/4th of the shares vest one year after May 7, 2018; 1/48th of the shares vest monthly thereafter over the next three years.